Wisdomtree Issuer ICAV - Wisdomtree Biorevolution UCITS ETF (LON:WBIO)
London
· Delayed Price · Currency is GBP · Price in GBX 1,048.90
-0.10 (-0.01%)
Apr 24, 2025, 4:35 PM BST
-20.33% (1Y)
| Assets | 3.76M |
| Expense Ratio | 0.45% |
| PE Ratio | 17.18 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -19.73% |
| Volume | 736 |
| Open | 1,041.20 |
| Previous Close | 1,049.00 |
| Day's Range | 1,026.60 - 1,056.00 |
| 52-Week Low | 905.70 |
| 52-Week High | 1,477.80 |
| Beta | 1.07 |
| Holdings | 88 |
| Inception Date | Dec 3, 2021 |
About WBIO
WDNA.IR was created on 2021-12-03 by WisdomTree. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 3.21m in AUM and 89 holdings. The WisdomTree BioRevolution UCITS ETF (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution ESG Screened Index (the Index).
Asset Class Equity
Category Theme
Stock Exchange London Stock Exchange
Ticker Symbol WBIO
Provider WisdomTree
Index Tracked WisdomTree BioRevolution Index
Performance
WBIO had a total return of -19.73% in the past year, including dividends. Since the fund's inception, the average annual return has been -16.29%.
Top 10 Holdings
27.66% of assets| Name | Symbol | Weight |
|---|---|---|
| Natera, Inc. | NTRA | 4.30% |
| Novonesis A/S | NSIS.B | 3.46% |
| Twist Bioscience Corporation | TWST | 3.37% |
| Eli Lilly and Company | LLY | 2.78% |
| BridgeBio Pharma, Inc. | BBIO | 2.76% |
| Blueprint Medicines Corporation | BPMC | 2.63% |
| Veracyte, Inc. | VCYT | 2.27% |
| Vericel Corporation | VCEL | 2.24% |
| Vertex Pharmaceuticals Incorporated | VRTX | 2.00% |
| United Therapeutics Corporation | UTHR | 1.86% |